NCT00112580View on ClinicalTrials.gov

MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

ipilimumab

Trial Locations (2)

20892

NCI - Surgery Branch, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Bristol-Myers Squibb

INDUSTRY